Corporate Banner
Satellite Banner
Biologics & Bioprocessing
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

CBST and BIA Separations Cooperate on Purification of Biomolecules

Published: Friday, September 21, 2012
Last Updated: Thursday, September 20, 2012
Bookmark and Share
Both Companies have signed a memorandum of understanding and entered into an agreement.

Centre for Bio Separations Technology (CBST)/VIT University and BIA Separations have announced that they have signed a Memorandum of Understanding on 31st August 2012 and entered into an agreement to cooperate and to work together towards:
• developing innovative bioseparation platforms and technologies,

• education and training of students to prepare them for working in biopharmaceutical industry

• providing technical support, contract research and services to the biopharmaceutical industry, through the setting up of a BIA Separations Platform of Excellence at CBST.

From CBST/VIT perspective, teaming up with BIA Separations will give CBST/VIT access to a unique and leading edge technologies and know-how in the field of downstream purification and separations of large bio-molecules.

Combining this technology and know-how with CBST/VIT excellence in "oriented research" and excellent scientific base, provide opportunities for bridging the gap between industry and academia, in the areas of bioseparations.

BIA Separations recognizes CBST/VIT academic and bioseparation excellence.

Therefore from BIA Separations perspective this partnership is very important for a successful implementation of BIA Separations technologies that would bring benefits to the biopharmaceutical industry and academic research not only in India but worldwide.

This partnership is also in-line with BIA Separations plans to establish BIA Separations India.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,200+ scientific posters on ePosters
  • More than 4,600+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
ASMS 2016: Targeting Mass Spectrometry Tools for the Masses
The expanding application range of MS in life sciences, food, energy, and health sciences research was highlighted at this year's ASMS meeting in San Antonio, Texas.
Long-Term Culturing of Adult Stem Cells
A new procedure developed by Harvard Stem Cell Institute researchers (HSCI) at Massachusetts General Hospital (MGH) may revolutionize the culturing of adult stem cells.
Solutions for Biotherapeutic Characterization
Innovation to speed the routine.
Plant-Based Vaccine Among Front Runners In Search For New Polio Jab
A researcher from Norwich is part of a consortium that has been awarded $1.5 million to develop safer polio vaccines, using a new technique developed at the John Innes Centre.
Harnessing Helpful Microbes
Seeking to further harness microbes’ many uses, the federal government has launched the National Microbiome Initiative (NMI) to “foster the integrated study of microbiomes across different ecosystems.”
What Makes a Good Scientist?
It’s the journey, not just the destination that counts as a scientist when conducting research.
A New Approach to Chemical Synthesis
Communesins, originally found in fungus, could hold potential as cancer drugs.
Better Animal Model to Improve HIV Vaccine Development
Penn study identifies a new tool to produce better HIV vaccine designs.
First Large-Scale Proteogenomic Study of Breast Cancer
The study offers understanding of potential therapeutic targets.
Developing a More Precise Seasonal Flu Vaccine
During the 2014-15 flu season, the poor match between the virus used to make the world’s vaccine stocks and the circulating seasonal virus yielded a vaccine that was less than 20 percent effective.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,200+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,600+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!